Pharsight

1. Fleqsuvy patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11446246	AZURITY	Suspensions and diluents for metronidazole and baclofen	Sep, 2037 (13 years from now)
US11324696	AZURITY	Suspensions and diluents for metronidazole and baclofen	Sep, 2037 (13 years from now)

Market Authorisation Date: 04 February, 2022

Treatment: Indicated for the treatment of spasticity resulting from multiple sclerosis

Dosage: SUSPENSION;ORAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
25 mg/5 mL	20 May, 2022	1	08 Jun, 2023	29 Sep, 2037	Eligible

Strength	Dosage	Availability
25MG/5ML	SUSPENSION;ORAL	Prescription

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6024981	UCB INC	Rapidly dissolving robust dosage form	Apr, 2018 (6 years ago)
US6221392	UCB INC	Rapidly dissolving robust dosage form	Apr, 2018 (6 years ago)

Market Authorisation Date: 30 October, 2003

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

Strength	Dosage	Availability
20MG	TABLET, ORALLY DISINTEGRATING;ORAL	Discontinued
10MG	TABLET, ORALLY DISINTEGRATING;ORAL	Discontinued

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792262	AMNEAL	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives	Jul, 2039 (15 years from now)
US11654124	AMNEAL	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives	Jul, 2039 (15 years from now)
US11491125	AMNEAL	Baclofen formulations and methods of minimizing patient exposure to metabolite variations	Sep, 2041 (17 years from now)

Market Authorisation Date: 22 November, 2021

Treatment: Method for treating spasticity; Treatment of spasticity resulting from spinal cord injuries and other spinal cord diseases

Dosage: GRANULES;ORAL

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry	Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610502	METACEL PHARMS LLC	Oral baclofen solutions	Aug, 2039 (15 years from now)

Market Authorisation Date: 18 September, 2019

Treatment: Treatment of spasticity

Dosage: SOLUTION;ORAL